DK37888A - Cannabinolderivat - Google Patents

Cannabinolderivat

Info

Publication number
DK37888A
DK37888A DK037888A DK37888A DK37888A DK 37888 A DK37888 A DK 37888A DK 037888 A DK037888 A DK 037888A DK 37888 A DK37888 A DK 37888A DK 37888 A DK37888 A DK 37888A
Authority
DK
Denmark
Prior art keywords
derivative
group
cannabinol
aminoalkyl group
derivatives
Prior art date
Application number
DK037888A
Other languages
Danish (da)
English (en)
Other versions
DK37888D0 (da
Inventor
Alan Joseph Mcnally
Alan Schwartz
Magdalena Usategui
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK37888D0 publication Critical patent/DK37888D0/da
Publication of DK37888A publication Critical patent/DK37888A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948Sedatives, e.g. cannabinoids, barbiturates
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK037888A 1987-01-27 1988-01-26 Cannabinolderivat DK37888A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/007,838 US4833073A (en) 1987-01-27 1987-01-27 Immunoassay for tetrahydrocannabinol metabolites

Publications (2)

Publication Number Publication Date
DK37888D0 DK37888D0 (da) 1988-01-26
DK37888A true DK37888A (da) 1988-07-28

Family

ID=21728380

Family Applications (1)

Application Number Title Priority Date Filing Date
DK037888A DK37888A (da) 1987-01-27 1988-01-26 Cannabinolderivat

Country Status (12)

Country Link
US (1) US4833073A (sv)
EP (1) EP0276732B1 (sv)
JP (1) JPH0819117B2 (sv)
AT (1) ATE97895T1 (sv)
AU (1) AU614733B2 (sv)
DE (1) DE3885911T2 (sv)
DK (1) DK37888A (sv)
ES (1) ES2060610T3 (sv)
FI (1) FI96685C (sv)
HK (1) HK63595A (sv)
NO (1) NO171274C (sv)
NZ (1) NZ223289A (sv)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264373A (en) * 1987-02-17 1993-11-23 Abbott Laboratories Fluorescence polarization immunoassay for tetrahydrocannabinoids
EP0392332A3 (de) * 1989-04-12 1992-01-08 F. Hoffmann-La Roche Ag Fluoreszenzpolarisationsimmunoassay und Reagentien dafür
US5001743A (en) * 1990-01-10 1991-03-19 Northern Telecom Limited Method and apparatus for controlling a telephone answering device
IL99468A (en) * 1991-09-12 1997-09-30 Yissum Res Dev Co (3s, 4s)-delta- 6-tetrahydrocannabinol- 7-oic acids and derivatives thereof, processes for their preparation and pharmaceutical compositions containing them
US5460944A (en) * 1991-10-28 1995-10-24 Boehringer Mannheim Gmbh Storable protein solution
US5292899A (en) * 1991-11-27 1994-03-08 Synthetic Technology Corporation Synthesis of 11-nor-Δ-9-tetrahydrocannabinol-9-carboxylic acid glucuronide
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5315015A (en) * 1992-11-10 1994-05-24 Hoffmann-La Roche Inc. Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same
US5817766A (en) * 1995-04-05 1998-10-06 Roche Diagnostic Systems, Inc. Reagents for a cannabinoid immunoassay
ES2224658T3 (es) * 1998-05-04 2005-03-01 The University Of Connecticut Nuevos canabinoides selectivos hacia el receptor cb2.
US7897598B2 (en) 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7589220B2 (en) 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US6248598B1 (en) 1998-09-17 2001-06-19 Stuart C. Bogema Immunoassay that provides for both collection of saliva and assay of saliva for one or more analytes with visual readout
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
JP2002539246A (ja) 1999-03-22 2002-11-19 イミュジェン ファーマシューティカルズ インコーポレイティッド 免疫疾患の治療
US7119108B1 (en) 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6943266B1 (en) 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US7393842B2 (en) 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US8084467B2 (en) 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7741365B2 (en) 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
CA2387764A1 (en) 1999-10-18 2001-04-26 University Of Connecticut Peripheral cannabinoid receptor (cb2) selective ligands
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
JP2004532185A (ja) 2001-01-26 2004-10-21 ユニバーシティ オブ コネチカット 新規なカンナビミメティックリガンド
CA2436133A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
US7057076B2 (en) 2001-07-13 2006-06-06 University Of Connecticut Bicyclic and tricyclic cannabinoids
EP1448557A4 (en) 2001-10-26 2005-02-02 Univ Connecticut HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
CA2496097A1 (en) * 2002-08-23 2004-03-04 University Of Connecticut Keto cannabinoids with therapeutic indications
US7195882B2 (en) * 2003-06-03 2007-03-27 Roche Diagnostics Operations, Inc. Monoclonal antibodies specific for buprenorphine and metabolites thereof
CA2530211C (en) 2003-07-01 2011-10-04 Eric R. Diebold Electrochemical affinity biosensor system and methods
US20060051824A1 (en) * 2004-09-03 2006-03-09 Haoyun An Tetrahydrocannabinoid antigens and method of use
GB0725234D0 (en) * 2007-12-24 2008-02-06 Oxtex Ltd Electrochemical assays
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
US10254298B1 (en) 2015-03-25 2019-04-09 National Technology & Engineering Solutions Of Sandia, Llc Detection of metabolites for controlled substances
US10458963B2 (en) 2016-06-08 2019-10-29 Kathleen Stitzlein Quantitative HPTLC cannabinoid field testing device and method
US10981174B1 (en) 2016-08-04 2021-04-20 National Technology & Engineering Solutions Of Sandia, Llc Protein and nucleic acid detection for microfluidic devices
WO2021139740A1 (zh) * 2020-01-08 2021-07-15 成都百裕制药股份有限公司 四氢大麻酚衍生物及其制备方法和在医药上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
IL39323A (en) * 1971-05-14 1975-08-31 Syva Co Highly sensitive assay method employing an enzyme for amplification
US4438207A (en) * 1979-09-26 1984-03-20 Hoffmann-La Roche Inc. Radioimmunoassay for cannabinoids
US4378428A (en) * 1981-03-30 1983-03-29 Baker Instruments Corporation Method for carrying out non-isotopic immunoassays, labeled analytes and kits for use in such assays
US4652681A (en) * 1982-04-15 1987-03-24 Drug Science Foundation Aminoalkoxy derivatives of propranolol for immunoassay applications
US4650771A (en) * 1983-11-04 1987-03-17 Miles Laboratories, Inc. Immunogens, antibodies, labeled conjugates, and related derivatives for lidocaine and analogs thereof

Also Published As

Publication number Publication date
US4833073A (en) 1989-05-23
EP0276732B1 (en) 1993-12-01
EP0276732A2 (en) 1988-08-03
FI880332A (sv) 1988-07-28
JPS63192770A (ja) 1988-08-10
FI880332A0 (sv) 1988-01-26
FI96685B (sv) 1996-04-30
EP0276732A3 (en) 1989-02-22
ES2060610T3 (es) 1994-12-01
JPH0819117B2 (ja) 1996-02-28
HK63595A (en) 1995-05-05
DE3885911T2 (de) 1994-03-24
NO880330D0 (no) 1988-01-26
DK37888D0 (da) 1988-01-26
FI96685C (sv) 1996-08-12
NZ223289A (en) 1989-06-28
NO880330L (no) 1988-07-28
ATE97895T1 (de) 1993-12-15
AU1111588A (en) 1988-07-28
AU614733B2 (en) 1991-09-12
DE3885911D1 (de) 1994-01-13
NO171274B (no) 1992-11-09
NO171274C (no) 1993-02-17

Similar Documents

Publication Publication Date Title
DK37888D0 (da) Cannabinolderivat
DE3880383D1 (de) Vernetzungsmittel zur haarbehandlung.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
ES2182054T3 (es) Derivados de oxazol, su produccion y uso.
DE69609108T2 (de) Verbesserte Immunoessayreagenzien zum Nachweis von Kannabinoiden
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
DE3882895D1 (de) Imid-derivate, ihre herstellung und verwendung.
ATE72831T1 (de) Konjugate von glucose-6-phosphat-dehydrogenase, ihre herstellung und verwendung.
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
ES2046229T3 (es) Composicion antiulcerosa.
DK21287A (da) Penemderivater
ATE60328T1 (de) Derivate vom benzoquinonylphenylalkansaeure-amid.
SE8506015D0 (sv) Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
KR890008151A (ko) 키놀린 카르복산의 유도체
ES2041790T3 (es) Derivados de tetrahidroisoquinolina amino-substituidos y su procedimiento de obtencion.
ES2058499T3 (es) Procedimiento para la preparacion de derivados de penicilina 2 beta-metil sustituidos.
ES2018874B3 (es) Derivado taurine, su preparacion y composiciones farmaceuticas que lo contiene
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
DE3861545D1 (de) Aminoverbindungen und diese enthaltende fungizide.
ES2040223T3 (es) Derivados de la tiadiazolilacetamida, procedimiento para su fabricacion y su utilizacion.
KR890002190A (ko) 퀴놀린 카르본산 유도체
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
PT88464A (pt) Process for the preparation of a macrolide compound
KR890001956A (ko) 안식향산 유도체

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment